Abstract
The hMSCs have become a promising approach for inflammation treatment in acute phase. Our previous study has demonstrated that human umbilical cord-MSCs could alleviate the inflammatory reaction of severely burned wound. In this study, we further investigated the potential role and mechanism of the MSCs on severe burn-induced excessive inflammation. Wistar rats were randomly divided into following groups: Sham, Burn, Burn+MSCs, Burn+MAPKs inhibitors and Burn, Burn+MSCs, Burn+Vehicle, Burn+siTSG-6, Burn+rhTSG-6 in the both experiments. It was found that MSCs could only down-regulate P38 and JNK signaling, but had no effect on ERK in peritoneal macrophages of severe burn rats. Furthermore, suppression of P38 and JNK activations significantly reduced the excessive inflammation induced by severe burn. TSG-6 was secreted by MSCs using different inflammatory mediators. TSG-6 from MSCs and recombinant human (rh)TSG-6 all significantly reduced activations of P38 and JNK signaling induced by severe burn and then attenuated excessive inflammations. On the contrary, knockdown TSG-6 in the cells significantly increased phosphorylation of P38 and JNK signaling and reduced therapeutic effect of the MSCs on excessive inflammation. Taken together, this study suggested TSG-6 from MSCs attenuated severe burn-induced excessive inflammation via inhibiting activation of P38 and JNK signaling.
Similar content being viewed by others
Introduction
Severe burn is a devastating trauma with systemic consequences1. Severe burn triggers an excessive inflammations and serious metabolic disturbances2. Meanwhile, excessive inflammation is possibly an important contributor to other systemic disorders such as cardiac dysfunction, acute respiratory distress syndrome, acute renal failure, intestinal bacterial translocation, hypermetabolism and sepsis3. These intense disruptions in body’s homeostatic balance will result in multiple organ failure and even death4. Therefore, research for seeking new treatments to attenuate excessive inflammation after severely burned injury is very necessary, especially in the acute phase.
Numerous reports have described that intravenously infused human mesenchymal stem cells (hMSCs) modulated excessive inflammation and thereby improved myocardial infarction, corneal injury, peritonitis, systemic lupus erythematosus, ulcerative colitis, or hepatic fibrosis in animal models5,6,7,8,9,10. Our previous study has shown that human umbilical cord-MSCs transplantation can accelerate wound healing of severe burn rats through alleviating the inflammatory microenvironment of locally burned wound11. And the beneficial effects of hMSCs were explained in part by activation of the cells to secrete a variety of bioactive factors that modulated inflammatory and immune responses, limited progression of inflammation and enhanced tissue repair12,13. Among all the bioactive factors secreted by hMSCs, tumor necrosis factor (TNF)-a–stimulated gene/protein 6 (TSG-6) as a multipotent anti-inflammatory protein was a key natural modulator of inflammation14,15. TSG-6 was shown to modulate pro-inflammatory cytokine cascades and enhance injured tissue repair in several animal models16,17. For example, TSG-6 can suppress inflammatory reactions triggered by ischemia in the heart and thereby limit the destruction of cardiomyocytes by inhibiting neutrophils and monocytes/macrophages invading18. In transgenic mice, inactivation of the TSG-6 gene increased inflammatory responses and over-expression of the TSG-6 gene decreased inflammatory responses19,20. In addition, administration of the recombinant protein (rhTSG-6) largely improved arthritis and decreased inflammation in several murine models21,22.
MAPKs signaling play critical roles in regulation of inflammatory responses. The MAPKs including P38, c-Jun N-terminus kinase (JNK) and extracellular signal regulated kinase (ERK), were activated by cellular stress and proinflammatory cytokines23. Burned injury results in a cellular stress in the skin24. The P38 is activated in the skin wound after burned injury, whereas administration of P38 inhibitor in topical wound may reduce the adversely inflammatory responses25. Liu et al. showed TSG-6 secreted by mesenchymal stem cells inhibited lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through inhibiting the activation of nuclear factor (NF)-κB and MAPK pathways26. Therefore, based on the basis of our previous study, our present study was designed to further investigate the potential mechanism involving effects of human umbilical cord-MSCs on severe burn injury-induced excessive inflammation.
Materials and Methods
Cell Preparations
Institutional Review Board approval was obtained from the Human Research Protection Program at the First Affiliated Hospital to PLA General Hospital for all aspects of this study. The methods described were carried out in accordance with the approved guidelines and informed consent was obtained from all subjects. The human umbilical cord-MSCs were isolated from discarded umbilical cord donated with consensus from 5 full-term healthy fetuses were born via caesarean delivery (gestation age, 39–40 weeks), expanded in vitro and characterized as previously described27. In the following passages, abbreviation of human umbilical cord-MSCs was MSCs. MSCs of passages 3–8 were used for all the following experiments.
Cell treatments
MSCs were plated at 5000 cells/cm2 in 6-well plates with supplementation of 3 mL mesenchymal stem cell medium-serum free (MSCM-sf) (ScienCell Research Laboratories, San Diego, CA) and incubated for 1 day. The mediums were then replaced with 3 mL of MSCM-sf containing 10 ng/mL hTNF-α (Peprotech, USA), 100 ng/mL LPS (Sigma-Aldrich, USA), 10% sham serum and 10% burn serum at 24 hours post severe burn for continuous culturing. To confirm increased expression and synthesis of TSG-6, RNA and protein were extracted from aliquots of the cells and assayed for TSG-6 expression and synthesis by real-time PCR and Western blotting. The TSG-6 secreted into supernatant was detected by ELISA assay.
Transfection with siRNA for TSG-6
The lentiviral expression vector containing the TSG-6 siRNA sequence (GeneChem, Shanghai, China) was selected for specifically targeting TSG-6 knockdown, which was classified as Lenti-TSG-6-siRNA and Lenti-GFP-siRNA as negative control vector. The TSG-6 siRNA lentivirus vectors were generated by ligating the vector pGC-LV. TSG-6 siRNA oligonucleotide sequences are: Forward, 5′-CCGGTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAGAATTTTTG-3′; Reverse, 5′-AATTCAAAAATTCTCCGAACGTGTCACGTTCT CTTGAAACGTGACACGTTCGGAGAA-3′. The sequences of control siRNA are: Forward, 5′-CCGGGCAAGCTGACCCTGAAGTTCATCTCGAGATGAACTTCAG GGTCACGTTGCTTTTTG-3′, Reverse, 5′-AATTCAAAAAGCAAGCTGACCCTG AAGTTCATCTCGAGATGAACTTCAGGGTCACGTTGC-3′. The recombinant lentivirus was produced by cotransfecting HEK293T cells with pGC-LV-GFP-siRNA or pGC-LV-TSG-6-siRNA, pHelper 1.0 and pHelper 2.0 plasmid using Lipofectamine 2000 (GeneChem, Shanghai, China). MSCs were transduced with the prepared lentivirus (Lenti-TSG-6-siRNA or Lenti-GFP-siRNA). MSCs were plated at 5000 cells/cm2 in 6-well plates or T-75 culture bottles with 3 mL or 10 mL MSCM-sf without antibiotics. After incubation for 1 day, cells were transfected with 1 ml mixture of Lenti-TSG-6-siRNA or Lenti-GFP-siRNA according to the protocol provided by the manufacturer. Twelve hours later, the medium was replaced with MSCM-sf without antibiotics and these cells were incubated for 3–4 days sequentially28. After the efficiency of TSG-6 knockdown in MSCs of 6-well plates was evaluated using real-time quantitative RT-PCR and Western blot. Then MSCs in T-75 culture bottles were harvested with 0.25% trypsin and resuspended at 5 × 106 cells in 1 mL sterile PBS for the subsequent injection.
Animals and Reagents
All studies adhered to procedures consistent with the International Guiding Principles for Biomedical Research Involving Animals issued by the Council for the International Organizations of Medical Sciences (CIOMS.) and all experimental protocols were approved by the Institutional Animal Care and Use Committee at the First Affiliated Hospital to PLA General Hospital. Six-week-old male Wistar rats (180–220 g) were obtained from the local animal facility, housed at the Institute of Animal Experiments of the First Affiliated Hospital to PLA General Hospital in stables with a temperature of 22 °C, a relative humidity of 55% and a day/night cycle of 12/12 hours, with food and water ad libitum throughout the experiment.
Experimental Groups
The study was made up of two animal experiments. In the first experiment, 144 Wistar rats were randomly divided into 6 groups: Sham, Burn, Burn+MSCs (burn transplanted MSCs), Burn+SB (burn transplanted with specific inhibitor of P38, SB203580), Burn+SP (burn transplanted with specific inhibitor of JNK, SP600125), Burn+PD (burn transplanted with selective inhibitor of ERK, PD098059). In the second experiment, 120 Wistar rats were randomly divided into 5 groups: Burn, Burn+MSCs, Burn+Vehicle (burn transplanted MSCs transduced with Lenti-GFP-siRNA), Burn+siTSG-6 (burn transplanted MSCs transduced with Lenti-TSG-6-siRNA), Burn+rhTSG-6 (burn administered rhTSG-6). Each group in two experimental parts was divided equally into four subgroups of 6 rats according to the time points of euthanasia at 6 h, 12 h, 24 h, 48 h after severe burn.
Animal Model of Severely Burned Injury and Treatment
Rats were anesthetized by intraperitoneal injection of 300 mg/kg Avertin (20 mg/ml) (2,2,2-tribromoethanol, Sigma, USA)29. The dorsal and abdominal hair was removed completely, first with clippers and then through the application of Veet depilatory cream. Both whole backside and abdomen were placed in hot water (94 °C) for 12 s and 6 s, respectively. which caused 50% TBSA with a full-thickness burn30. Intraperitoneal injections of balanced salt solution (40 ml/kg) were immediately administered to prevent shock in all of groups in both experiments. Balanced salt solutions with 25 mg/kg SB203580, 30 mg/kg SP600125, 15 mg/kg PD98059 (Selleckchem, USA) were administered to the rats of Burn+SB, Burn+SP and Burn+PD groups in the first experiment, respectively31,32,33,34. The rats in the Burn+MSCs group immediately received a tail vein injection of 5 × 106 MSCs immediately after burn in the both experiments. The rats in the Burn+Vehicle and Burn+siTSG-6 groups received a tail vein injection of 5 × 106 MSCs transfected with Lenti-GFP-siRNA and Lenti-TSG-6-siRNA at the same time in the second experiment. The rats in the Burn and Burn+rhTSG-6 groups received a tail vein injection of 1 mL PBS and rhTSG-6 in 1 mL PBS (50 μg/mL) (Abnova, Taipei, Taiwan of China) at the same time, respectively. All rats in each group were clinically evaluated. The burn wound was then treated with 1% tincture of iodine and kept dry to prevent infection. The rats in the sham group were placed in water at 37 °C for 12 s and the other processes were the same as those applied to the burned rats. Wounds were left open and animals were sacrificed at defined time points after burn.
Specimen collection and detection
The blood samples were taken from aortaventralis at 6 h, 12 h, 24 h and 48 h after burn or sham burn. They were transferred immediately to heparin-containing tubes for blood routine examination and serums for the ELISA assay were collected by centrifugation. Meanwhile, samples of vital organs such as lung, kidney, heart, liver and spleen were collected. These samples were carefully removed and rinsed in PBS. Subsequently, every organ specimen was divided into two pieces. One piece of the organ specimen was stored in liquid nitrogen for ELISA assay or future molecular detection and another piece was fixed in 4% paraformaldehyde for HE staining and immunohistochemical examination.
To confirm regulation of MSCs/rhTSG-6 on MAPKs signals, rats in all groups were euthanized and resident macrophages in enterocoelia were harvested for western detection by washing the peritoneal cavity with 10 mL ice-cold D-Hanks solution.
Temperature examination
At 6 h, 12 h, 24 h and 48 h after burn, rectal temperatures were measured using an electronic thermometer (OMRON MC-341, Japan) by a small mammal rectal thermister inserted 8 to 10 cm beyond the anal sphincter. The ambient temperature of the environmentally controlled room was kept at 22 ± 1 °C with a 40% to 50% relative humidity.
Blood routine examination
The blood and serum samples were detected by the Central Institute of Clinical Chemistry and Laboratory Medicine of the First Affiliated Hospital to PLA General Hospital. A 4 mL aliquot of blood was taken for full blood count (FBC) analysis to determine all the whole blood parameters. FBC was analyzed using a Sysmex XE 2100 (Sysmex UK, Milton Keynes, UK) automated hematology analyzer within 2 hours of collection.
Histological analyses
After fixation with 4% paraformaldehyde for 1 week at room temperature, the specimens were embedded in paraffin and sectioned in a plane perpendicular to the incision. Five-micrometer-thick sections were prepared, deparaffinized in dimethylbenzene and rehydrated. Preparative sections were stained with H&E in accordance with standard procedures. Other sections were incubated with specific antibodies (monoclonal mouse antibodies against rat MPO, CD68; R&D Systems, Minneapolis, MN), followed by incubation with the corresponding secondary antibody and the PAP (peroxidase–anti-peroxidase) complex and stained with DAB (3,3′-diaminobenzidine). The OD value of neutrophil (MPO+) and number of macrophage (CD68+) in the lung, liver, heart, renal and spleen tissues were counted in 5 randomly selected fields of each slide by an experienced and independent cell scientist in a blinded manner.
GFP-fluorescence observation
To confirm successful transfection with Lenti-GFP-siRNA and Lenti-TSG-6-siRNA, we observed GFP fluorescence intensity and obtained images using the inverted fluorescence microscope (Leica, Germany).
Real Time-PCR Analysis
After cells treatments and cells transfection with Lenti-GFP-siRNA and Lenti-TSG-6-siRNA as described previously, MSCs were resuspended in 1 ml Trizol for RNA isolation. A reverse-transcription reaction was performed to generate cDNA for all samples. The cDNA was amplified using the following gene-specific primers, according to the manufacturer’s protocol (forward and reverse, respectively): TSG-6 (208 bp), 5′-GATGGATGGCTAAGGGCAGAGT-3′ and 5′-TCATTTGGGAA GCCTGGAGATT-3′; ACTIN (317 bp), 5′-CACCCAGCACAATGAAGATCAAGA T-3′ and 5′-CCAGTTTTTAAATCCTGAGTCAAGC-3′. Real-time PCR reactions were incubated at 95 °C for 2 min and then 40 cycles at 95 °C for 3 s followed by 60 °C for 30 s. Relative quantitation of gene expression in terms of fold change was performed using the 2−△△CT method.
Western Blotting
The treated MSCs and the peritoneal macrophages of severe rats were immediately extracted using RIPA buffer supplemented with Halt protease and a phosphatase inhibitor cocktail (Servicebio, Wuhan, China). Proteins were subjected to SDS-PAGE gel and anti-TSG-6 antibody (1:1,000), anti-P38 and anti-P-P38 antibodies (1:2,000), anti-JNK and anti-P-JNK antibodies (1:2,000), anti-ERK and anti-P-ERK antibodies and anti-β-actin antibody (1:20,000) (R&D Systems, Minneapolis, MN) were used for protein expression assay.
Enzyme-linked immunosorbent assay (ELISA)
The levels of tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10) , myeloperoxtidase (MPO) and TSG-6 in serum/supernatant/organ specimen were detected by a multidetection microplate reader using a double-antibody sandwich ELISA kit (eBioscience, USA) according to the manufacturer’s protocols.
Statistical analysis
All data were expressed as the mean ± SD ( ± s) and analyzed using SPSS 18.0 (SPSS Inc., Chicago, IL, USA). Statistical differences among the groups were assessed by one-way ANOVA and after hoc multiple comparisons were performed using Student-Newman-Keuls tests. The significance level was set at p < 0.05.
Results
Effects of MSCs and MAPKs inhibitors on MAPKs phosphorylations
To investigate whether MSCs regulated the pro-inflammatory MAPKs signals (including P38, JNK and ERK) or not, we examined the levels of phosphorylated P38, JNK and ERK in the peritoneal macrophages at 24 h after burn by Western blotting. As shown in Fig. 1A, phosphorylated P38, JNK and ERK in peritoneal macrophages of burn group were significantly increased compared with that of the sham group. MSCs administration markedly down-regulated the phosphorylated levels of P38 and JNK but not phosphorylated ERK (p < 0.05). In addition, as seen in Fig. 1B, the intraperitoneal injection of SB203580 prevented the burn-induced phosphorylation of P38, whereas phosphorylations of JNK and ERK were completely unaffected by SB203580. In the same way, administrations SP600125 and PD098059 also significantly decreased the corresponding levels of phosphorylated JNK and ERK and other signals were not affected. There was no change in total protein levels of P38, JNK and ERK in any group.
Suppression of P38 and JNK activations reduced the systemic inflammatory responses induced by severe burn
To investigate influence of inhibiting the activations of P38 and JNK signalings on the systemic inflammatory responses induced by severe burn, we assayed temperature, leukocyte counts and levels of pro-inflammatory and anti-inflammatory cytokines at 6 h, 12 h, 24 h and 48 h after severe burn. As shown in Fig. 2A, compared with sham group, severe burn-induced hypothermia and temperature of burned rats was lower than 36 °C at all time points. However, MSCs, SB203580 and SP600125 injections significantly improved hypothermia induced by severe burn. Temperature in burn+MSCs group was even close to normal value at 24 h and 48 h after injection. Likewise, MSCs, SB203580 and SP600125 injections significantly improved leukocyte counts, which were less than 4 × 109/L at 12 h, 24 h and 48 h after severe burn, to close to the normal value (Fig. 2B). It was also found that these injections markedly increased levels of the anti-inflammatory cytokines IL-10 and decreased levels of the pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6 in serum at 6 h, 12 h, 24 h, 48 h after severe burn (Fig. 2C–F).
Suppression of P38 and JNK activations reduced the inflammatory cells infiltrations in vital organs after severe burn
To investigate influence of inhibiting the activations of P38 and JNK signaling on the inflammatory cells infiltrations in vital organs at 24 h post severe burn, we evaluated the infiltrated degrees of the inflammatory cells in liver, kidney, lung, heart and spleen of all groups using histochemical staining. As shown in Fig. 3A, compared with that of sham group, the infiltrated degrees of total inflammatory cells in these vital organs of burn group were remarkably increased and they were markedly decreased by MSCs and SB203580 and SP600125 injections (p < 0.05). Further, the data showed that neutrophil (MPO+) and macrophage (CD68+) infiltrations in liver, kidney, lung, heart and spleen were also markedly increased after severe burn and their infiltrations were significantly decreased by MSCs and SB203580 and SP600125 injections (p < 0.05) (Fig. 3B,C). The quantitative analysis were reported in the corresponding histogram (Fig. 3D).
Suppression of P38 and JNK activations reduced levels of the inflammatory cytokines in vital organs after severe burn
To investigate direct effect of inhibiting the activations of P38 and JNK signaling on the inflammatory cytokines levels of vital organs at 24 h post severe burn, we evaluated the levels of TNF-α, IL-1β, IL-6 and MPO in liver, kidney, lung, heart and spleen of all groups using ELISA assay. As shown in Fig. 4A, compared with that in sham group, the levels of TNF-α in these vital organs of burn group were remarkably increased and they were significantly decreased after injection of MSCs, SB203580 and SP600125 (p < 0.05). Similarly, the levels of IL-1β, IL-6 and MPO in these vital organs of burn group were also remarkably increased compared to those in sham group and they were obviously reduced by MSCs, SB203580 and SP600125 administrations (p < 0.05) (Fig. 4B–D).
TSG-6 secretion and its function on regulating P38 and JNK activations
To elucidate the potential mechanisms responsible for the effects of MSCs on anti-inflammatory properties, we next tested the levels of TSG-6 gene/protein expressions and secretion and its function on regulating P38 and JNK activations. Data showed that the levels of mRNA, protein expressions and secretion of TSG-6 in MSCs after treatments with TNF-α, LPS and burn serum were significantly increased in vitro (Fig. 5A–C). It is worth noting that TSG-6 mRNA, protein and secretion levels of burn serum group were the highest in all treatment groups and its mRNA level was up to approximately 19-fold relative to that of sham serum group (Fig. 5A–C). In animal experiment, TSG-6 in serum of the burn+MSCs group was also significantly higher than that of burn group (Fig. 5D).
As shown in Fig. 5E, representative photographs demonstrated successful transfections with Lenti-GFP-siRNA and Lenti-TSG-6-siRNA. The efficiency of TSG-6 knockdown was approximately 85% by real time-PCR (Fig. 5F). Similar results were obtained by Western blotting for TSG-6 (Fig. 5G).
As shown in Fig. 5H, compared with that of burn group, the levels of phosphorylated P38 and JNK signalings of burn+vehicle and burn+rhTSG-6 groups were significantly decreased (p < 0.05). However, the levels of phosphorylated P38 and JNK signaling in burn+siTSG-6 group had no statistically significant compared to burn group (P > 0.05).
The effect of TSG-6 level on the systemic inflammatory responses induced by severe burn
To further evaluate the role of TSG-6 in the effect of MSCs on severe burn-induced excessive inflammation, we assayed effects of MSCs with knockdown TSG-6 and rhTSG-6 injections on temperature, leukocyte counts and levels of pro- inflammatory and anti-inflammatory cytokines after severe burn. It was revealed that injection of MSCs with knockdown TSG-6 slightly improved temperature and leukocyte counts at 6 h, 12 h, 24 h, 48 h post severe burn and no statistically significant (p > 0.05). But rhTSG-6 administration significantly improved temperature and leukocyte counts compared to burn group (p < 0.05) (Fig. 6A,B). Furthermore, the therapeutic effects of the MSCs on anti-inflammatory cytokines of IL-10 and pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6 in serum after severe burn were significantly reduced by MSCs with knockdown TSG-6. However, rhTSG-6 administration greatly improved levels of these inflammatory cytokines. (Fig. 6C–F).
The effect of TSG-6 level on the inflammatory cells infiltrations induced by severe burn
Next, we further assayed the influence of MSCs with knockdown TSG-6 and rhTSG-6 injections on infiltrations of total inflammatory cells, neutrophils and macrophages in liver, kidney, lung, heart and spleen at 24 h post severe burn. Compared with that in burn group, the infiltration degrees of total inflammatory cells, neutrophils, macrophages in these vital organs in groups of the burn+MSCs, burn+Vehicle and burn+rhTSG-6 were markedly decreased (p < 0.05). Meanwhile, the infiltration degrees of these inflammatory cells in these vital organs of burn+siTSG-6 group were slightly decreased compared to burn group, but they were remarkable increased compared with that of burn+MSCs group. Furthermore, the ameliorative effect of these inflammatory cells infiltration degrees in the burn+rhTSG-6 group were approximately the effects of burn+MSCs group (Fig. 7A–C). The quantitative analysis was reported in the corresponding histogram (p < 0.05) (Fig. 7D).
The effect of TSG-6 level on expression of the inflammatory cytokines in the vital organs induced by severe burn
Finally, we further analyzed the influence of MSCs with knockdown TSG-6 or rhTSG-6 injections on levels of the inflammatory cytokines, such as TNF-α, IL-1β, IL-6 and MPO in liver, kidney, lung, heart and spleen of all groups at 24 h post severe burn. Compared with that of burn group, the levels of TNF-α, IL-1β, IL-6 and MPO in these vital organs in groups of the burn+MSCs, burn+Vehicle and burn+rhTSG-6 were also significantly decreased (p < 0.05) and they were slightly decreased in burn+siTSG-6 group (p > 0.05). In addition, we found that the therapeutic effect of MSCs on inflammatory cytokines levels in vital organs were heavily reduced after TSG-6 knockdown, but rhTSG-6 administration got a good anti-inflammatory effects, even approximately the therapeutic effects of MSCs (Fig. 8A–D).
In short, these data showed that anti-inflammatory protein TSG-6 from MSCs in the effect of the cells on severe burn-induced excessive inflammation played a key role.
Discussion
In recent years, human umbilical cord-MSCs can be considered the perfect candidates for cell-based therapies and regenerative medicine. Human umbilical cord-MSCs can repair the damaged tissues and modulate immune systems35. It has been demonstrated that hMSCs are able to attenuate the inflammatory reaction of systemic lupus erythematosus, ulcerative colitis, hepatic fibrosis and other diseases6,10,36,37. In this study, we also found that human umbilical cord-MSCs administration could significantly reduce severely burned injury-induced the excessive inflammation, including hypothermia, low numbers of leukocyte counts, undesirably high levels of pro-inflammatory cytokines and inflammatory cells infiltrations in vital organs, which were necessary diagnostic criteria of excessive inflammation30. On this basis, we further investigated the potential anti-inflammatory mechanisms of human umbilical cord-MSCs.
After severe burn, immune defense system from organism was initiated, subsequently a large number of neutrophils and macrophages were recruited and activated. Pro-inflammatory cytokines such as TNF-α, IL-1 and IL-6 from the hyperactive macrophages through activating internal pro-inflammatory signaling pathways, which in turn activated macrophages, resulting in a pro-inflammatory cascade reactions. Activated macrophages are a major source of inflammation related molecules38,39. Therefore, peritoneal macrophage from severely burned rats was chosen as study object to elucidate direct pro-inflammatory and anti-inflammatory mechanisms.
The MAPKs pathways, activated by cellular stress and proinflammatory cytokines, play critical roles in regulation of inflammatory responses40. The P38 signaling was activated in the skin wound after burned injury and inhibiting P38 in topical wound could reduce the adverse inflammatory responses25. Other studies reported that inhibiting the activation of MAPKs signaling can significantly reduce inflammation and improve histological and functional outcomes of severe trauma40,41,42. For example, MAPK/NF-κB signaling pathways were activated in the brain after traumatic brain injury (TBI) contributing to neuronal death and inhibition of MAPKs activation may have decreased adverse inflammatory response events and reduced the loss of neuronal cells after TBI43,44. Our study also showed that MAPKs signaling were activated immediately after severe burn, but human umbilical cord-MSCs only down-regulated levels of phosphorylated P38 and JNK after severe burn and the level of phosphorylated ERK was unaffected. In addition, suppression of P38 and JNK activations significantly reduced excessive inflammation, including the systemic inflammatory responses, inflammatory cells infiltrations and the inflammatory cytokines levels, which were induced by severe burn in vital organs. The above results suggested that human umbilical cord-MSCs attenuated severe burn-induced excessive inflammation via inhibiting pro-inflammatory P38 and JNK signaling but not ERK.
Recent investigations have shown that MSC paracrine signaling is the primary mechanism accounting for the beneficial effects of MSC in response to injury45,46. The bioactive factors of nitric oxide synthase, indoleamine 2,3-dioxygenase, prostaglandin E2 and TSG-6 secreted by MSCs in response to tissue injury got good anti-inflammatory effects13,47,48. The synthesis and secretion of TSG-6 in MSCs were induced by the pro-inflammatory cytokines18,35. Transplanted MSCs played a crucial role in the suppression of inflammation in models of myocardial infarction and corneal injury and these anti-inflammatory effects may be attributable to the secretion of TSG-6 by MSCs5. In this study, human umbilical cord-MSCs were activated by burn serum and soluble inflammatory mediators such as LPS and TNF-α to express and secrete TSG-6 in vitro and in vivo. Furthermore, TSG-6 levels in burn serum group were the highest in all of the treatment groups in vitro. That maybe because burn serum contained multiple stimulating factors, including inflammatory cytokines, burned factors, enzymes and other factors, which induced TSG-6 expression and secretion. Most importantly, TSG-6 level in serum of the burn+MSCs group was significantly higher than that of burn group in vivo. The above data immediately indicated that TSG-6 from human umbilical cord-MSCs might play a very key role in the effect of the cells on severe burn-induced excessive inflammation.
We further evaluated TSG-6 in the effect of human umbilical cord-MSCs on severe burn-induced excessive inflammation and observing influence of MSCs with knockdown TSG-6 and rhTSG-6 injections on the pro-inflammatory signals, systemic inflammatory responses, inflammatory cells infiltrations and inflammatory cytokines levels in vital organs. Data revealed that human umbilical cord-MSCs and rhTSG-6 administrations significantly suppressed severe burn-induced activations of P38 and JNK signaling, which subsequently reduced excessive inflammations. On the contrary, MSCs with TSG-6 knockdown significantly increased levels of phosphorylated P38 and JNK signaling and also reduced the therapeutic effect of the human umbilical cord-MSCs on excessive inflammation. These comprehensive data from the pro and con two aspects showed that TSG-6 from human umbilical cord-MSCs attenuates severe burn-induced excessive inflammation via inhibiting the activations of P38 and JNK signaling pathways. In addition, some studies also showed that the anti-inflammatory proteins from hMSCs could inhibit inflammations induced by some diseases or trauma through inhibiting activations of pro-inflammatory signaling6,23,49. A study indicated that rhTSG-6 administration also could attenuate acute lung injury-induced inflammatory response and down-regulate the pro-inflammatory signaling activations50.
Conclusions
In summary, these data suggest that anti-inflammatory protein TSG-6 secreted by human umbilical cord-MSCs attenuates excessive inflammation in rats after severe burn injury via inhibiting the activations of P38 and JNK signaling pathways. Moreover, these data might provide the theoretical foundation for further clinical applications of human umbilical cord-MSC in burn areas.
Additional Information
How to cite this article: Liu, L. et al. TSG-6 secreted by human umbilical cord-MSCs attenuates severe burn-induced excessive inflammation via inhibiting activations of P38 and JNK signaling. Sci. Rep. 6, 30121; doi: 10.1038/srep30121 (2016).
References
Xue, L. et al. Effects of human bone marrow mesenchymal stem cells on burn injury healing in a mouse model. International journal of clinical and experimental pathology 6, 1327–1336 (2013).
Dahiya, P. Burns as a model of SIRS. Frontiers in bioscience 14, 4962–4967 (2009).
Kott, M. et al. Acid sphingomyelinase serum activity predicts mortality in intensive care unit patients after systemic inflammation: a prospective cohort study. PloS one 9, e112323 (2014).
Hatakeyama, N. & Matsuda, N. Alert cell strategy: mechanisms of inflammatory response and organ protection. Current pharmaceutical design 20, 5766–5778 (2014).
Lee, R. H. et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell stem cell 5, 54–63 (2009).
Roddy, G. W. et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-alpha stimulated gene/protein 6. Stem cells 29, 1572–1579 (2011).
Wang, N. et al. Novel mechanism for mesenchymal stem cells in attenuating peritoneal adhesion: accumulating in the lung and secreting tumor necrosis factor alpha-stimulating gene-6. Stem cell research & therapy 3, 51 (2012).
Wang, N. et al. Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6. PloS one 7, e43768 (2012).
Sun, T. et al. Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice. American journal of translational research 7, 891–901 (2015).
Lee, R. H. et al. TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proceedings of the National Academy of Sciences of the United States of America 111, 16766–16771 (2014).
Liu, L. et al. Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats. PloS one 9, e88348 (2014).
Meirelles Lda, S., Fontes, A. M., Covas, D. T. & Caplan, A. I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & growth factor reviews 20, 419–427 (2009).
Beltran, S. R., Svoboda, K. K., Kerns, D. G., Sheth, A. & Prockop, D. J. Anti-inflammatory protein tumor necrosis factor-alpha-stimulated protein 6 (TSG-6) promotes early gingival wound healing: an in vivo study. Journal of periodontology 86, 62–71 (2015).
Watanabe, J. et al. Administration of TSG-6 improves memory after traumatic brain injury in mice. Neurobiology of disease 59, 86–99 (2013).
Wang, S. et al. Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury. Stem cell research & therapy 6, 20 (2015).
Milner, C. M., Higman, V. A. & Day, A. J. TSG-6: a pluripotent inflammatory mediator? Biochemical Society transactions 34, 446–450 (2006).
Wisniewski, H. G. & Vilcek, J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine & growth factor reviews 15, 129–146 (2004).
Prockop, D. J. & Oh, J. Y. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Molecular therapy: the journal of the American Society of Gene Therapy 20, 14–20 (2012).
Szanto, S., Bardos, T., Gal, I., Glant, T. T. & Mikecz, K. Enhanced neutrophil extravasation and rapid progression of proteoglycan-induced arthritis in TSG-6-knockout mice. Arthritis and rheumatism 50, 3012–3022 (2004).
Mindrescu, C. et al. Reduced susceptibility to collagen-induced arthritis in DBA/1J mice expressing the TSG-6 transgene. Arthritis and rheumatism 46, 2453–2464 (2002).
Bardos, T., Kamath, R. V., Mikecz, K. & Glant, T. T. Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-alpha-stimulated gene-6) in murine models of experimental arthritis. The American journal of pathology 159, 1711–1721 (2001).
Mindrescu, C., Thorbecke, G. J., Klein, M. J., Vilcek, J. & Wisniewski, H. G. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein. Arthritis and rheumatism 43, 2668–2677 (2000).
Qiu, J. L. et al. The selective mGluR5 agonist CHPG attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-kappaB pathway in BV2 microglial cells. Neurochemistry international 85–86, 46–52 (2015).
Arno, A. et al. Stem Cell Therapy: A New Treatment for Burns? Pharmaceuticals 4, 1355–1380 (2011).
Ipaktchi, K. et al. Attenuating burn wound inflammatory signaling reduces systemic inflammation and acute lung injury. Journal of immunology 177, 8065–8071 (2006).
Liu, Y. et al. Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. Journal of neuroinflammation 11, 135 (2014).
Liu, L. Y. et al. Basic fibroblast growth factor/vascular endothelial growth factor in the serum from severe burn patients stimulates the proliferation of cultured human umbilical cord mesenchymal stem cells via activation of Notch signaling pathways. The journal of trauma and acute care surgery 75, 789–797 (2013).
Li, B. et al. Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL. Nature medicine 21, 563–571 (2015).
Chu, W. L. et al. [Expressions of endoplasmic reticulum stress associated proteins in livers of severely burned rats]. Zhonghua yi xue za zhi 92, 853–856 (2012).
Liu, L. et al. Comparison of systemic inflammation response and vital organ damage induced by severe burns in different area. International journal of clinical and experimental pathology 8, 6367–6376 (2015).
Costantini, T. W. et al. Role of p38 MAPK in burn-induced intestinal barrier breakdown. The Journal of surgical research 156, 64–69 (2009).
Eynott, P. R. et al. Effect of an inhibitor of Jun N-terminal protein kinase, SP600125, in single allergen challenge in sensitized rats. Immunology 112, 446–453 (2004).
Lee, M. J., Jang, M., Jung, H. S., Kim, S. H. & Cho, I. H. Ethyl pyruvate attenuates formalin-induced inflammatory nociception by inhibiting neuronal ERK phosphorylation. Molecular pain 8, 40 (2012).
Nemoto, W. et al. Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice. Molecular pain 9, 38 (2013).
Choi, H., Lee, R. H., Bazhanov, N., Oh, J. Y. & Prockop, D. J. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118, 330–338 (2011).
Sheikh, A. M. et al. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5. Neurobiology of disease 41, 717–724 (2011).
Lee, J. K. et al. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer’s disease mice by modulation of immune responses. Stem cells 28, 329–343 (2010).
Chen, X. L. et al. High-mobility group box-1 induces proinflammatory cytokines production of Kupffer cells through TLRs-dependent signaling pathway after burn injury. PloS one 7, e50668 (2012).
Sun, X. et al. Anti-inflammatory effect of Impatiens textori Miq. extract via inhibition of NLRP3 inflammasome activation in in vitro and in vivo experimental models. Journal of ethnopharmacology 170, 81–87 (2015).
Kim, D. S. et al. Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-kappaB Pathway in Mouse Peritoneal Macrophages. The American journal of Chinese medicine 43, 731–742 (2015).
Guo, S. X. et al. Effects of hydrogen-rich saline on early acute kidney injury in severely burned rats by suppressing oxidative stress induced apoptosis and inflammation. Journal of translational medicine 13, 183 (2015).
Bettaieb, A. et al. Effects of soluble epoxide hydrolase deficiency on acute pancreatitis in mice. PloS one 9, e113019 (2014).
Chu, W. et al. Immediate splenectomy down-regulates the MAPK-NF-kappaB signaling pathway in rat brain after severe traumatic brain injury. The journal of trauma and acute care surgery 74, 1446–1453 (2013).
Zhang, R. et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. Journal of neuroinflammation 10, 106 (2013).
Hocking, A. M. & Gibran, N. S. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Experimental cell research 316, 2213–2219 (2010).
Gnecchi, M., Zhang, Z., Ni, A. & Dzau, V. J. Paracrine mechanisms in adult stem cell signaling and therapy. Circulation research 103, 1204–1219 (2008).
Noone, C., Kihm, A., English, K., O’Dea, S. & Mahon, B. P. IFN-gamma stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro. Stem cells and development 22, 3003–3014 (2013).
Shi, Y. et al. How mesenchymal stem cells interact with tissue immune responses. Trends in immunology 33, 136–143 (2012).
Gu, W. et al. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Scientific reports 5, 8733 (2015).
Xu, J., Zheng, J. & Zhu, J. [Tumor necrosis factor-alpha induced protein 6 attenuates acute kidney injury following paraquat poisoning in rats]. Zhonghua wei zhong bing ji jiu yi xue 26, 405–408 (2014).
Acknowledgements
This work was supported by four research projects of National Natural Science Foundation of China (81372052), (81501694), (81471873) and the Nursery Fund of PLA General Hospital (14KMM22).
Author information
Authors and Affiliations
Contributions
L.-Y.L., H.S. and H.D.: conception and design, collection and assembly of data, data analysis and interpretation and manuscript writing; and J.-K.C.: conception and design, financial support, data interpretation and final approval of the manuscript. J.Y., X.L., Y.Y., X.Z., X.H., M.X., R.F., H.Y., Q.H., L.Y., J.D. and T.L.: provision of study material, data analysis and interpretation. L.-Y.L., H.S. and H.D. contributed equally to this study.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Liu, L., Song, H., Duan, H. et al. TSG-6 secreted by human umbilical cord-MSCs attenuates severe burn-induced excessive inflammation via inhibiting activations of P38 and JNK signaling. Sci Rep 6, 30121 (2016). https://doi.org/10.1038/srep30121
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep30121
- Springer Nature Limited
This article is cited by
-
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review
Stem Cell Research & Therapy (2022)
-
Evaluation the ability of acellular ovine small intestine submucosa to load and release of mineral pitch and its anti-inflammatory effects
Cell and Tissue Banking (2022)
-
Multifactorial pathways in burn injury-induced chronic pain: novel targets and their pharmacological modulation
Molecular Biology Reports (2022)
-
MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy
Stem Cell Research & Therapy (2021)
-
Recombinant TSG-6 protein inhibits the growth of capsule fibroblasts in frozen shoulder via suppressing the TGF-β/Smad2 signal pathway
Journal of Orthopaedic Surgery and Research (2021)